Provided are compounds of the formula I: ##STR00001## and pharmaceutically acceptable salts thereof, processes for making said compounds and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said compound and pharmaceutically acceptable salts thereof, and methods of using said compounds. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.

 
Web www.patentalert.com

< Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor

> 3,4-dihydro-1H-isoquinolin-2-yl-derivatives

~ 00439